Insertional mutagenesis of AAV2 capsid and the production of recombinant virus

被引:99
|
作者
Rabinowitz, JE
Xiao, WD
Samulski, RJ
机构
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
[2] Univ Penn, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
关键词
D O I
10.1006/viro.1999.0045
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The structural genes of adeno-associated virus serotype 2 (AAVP) have been altered by linker insertional mutagenesis in order to define critical components of virion assembly and infectivity. An in-frame restriction site linker was inserted across the capsid coding domain of a recombinant plasmid. After complementation in vivo, recombinant AAV2 viruses were generated and assayed for capsid production, packaging, transduction, heparin agarose binding, and morphology. Three classes of capsid mutants where identified. Class I mutants expressed structural proteins but were defective in virion assembly. Class II mutants generated intact virions that protected the viral genome from DNase, but failed to infect target cells. The majority of these mutants bound the heparin affinity matrix, suggesting that attachment to the AAV primary receptor was not rate limiting. One class II mutant, H2634, assembled virions and bound heparin using only Vp3, indicating that this subunit is responsible for mediating AAV receptor attachment. Finally, class III mutants assembled virions, encapsidated DNA, and infected target cells. Infectivity of these mutants ranged from 5 to 100% of that of the wild-type, demonstrating for the first time the ability to alter capsid proteins without interfering with infectivity. These AAV virions with altered capsid subunits will provide critical templates for manipulating AAV vectors for cell-specific gene delivery in vivo. In summary, the AAV capsid variants described here will facilitate further study of virus assembly, entry, and infection, as well as advance the development of this versatile vector system. (C) 1999 Academic Press.
引用
收藏
页码:274 / 285
页数:12
相关论文
共 50 条
  • [1] Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors
    Shi, WF
    Arnold, GS
    Bartlett, JS
    [J]. HUMAN GENE THERAPY, 2001, 12 (14) : 1697 - 1711
  • [2] Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin binding ability and introduced novel tropism
    Shi, XQ
    Fang, GG
    Shi, WF
    [J]. HUMAN GENE THERAPY, 2006, 17 (03) : 353 - 361
  • [3] ADENO-ASSOCIATED VIRUS 2 (AAV2) INDUCES RECURRENT INSERTIONAL MUTAGENESIS IN HUMAN HEPATOCELLULAR CARCINOMAS
    Nault, J. C.
    Datta, S.
    Franconi, A.
    Imbeaud, S.
    Mallet, M.
    Couchy, G.
    Letouze, E.
    Pilati, C.
    Verret, B.
    Blanc, J. F.
    Balabaud, C.
    Calderaro, J.
    Laurent, A.
    Lextexier, M.
    Bioulac-Sage, P.
    Calvo, F.
    Zucman-Rossi, J.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S406 - S406
  • [4] Adeno-associated virus 2 (AAV2) induces recurrent insertional mutagenesis in human hepatocellular carcinomas
    Datta, Shalini
    Nault, Jean-Charles
    Franconi, Andrea
    Imbeaud, Sandrine
    Mallet, Maxime
    Couchy, Gabrielle
    Letouze, Eric
    Pilati, Camilla
    Verret, Benjamin
    Blanc, Jean-Frederic
    Balabaud, Charles
    Calderaro, Julien
    Laurent, Alexis
    Letexier, Melanie
    Bioulac-Sage, Paulette
    Calvo, Fabien
    Zucman-Rossi, Jessica
    [J]. CANCER RESEARCH, 2015, 75
  • [5] Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
    Aslanidi, George V.
    Rivers, Angela E.
    Ortiz, Luis
    Song, Liujiang
    Ling, Chen
    Govindasamy, Lakshmanan
    Van Vliet, Kim
    Tan, Mengqun
    Agbandje-McKenna, Mavis
    Srivastava, Arun
    [J]. PLOS ONE, 2013, 8 (03):
  • [6] AAV and insertional mutagenesis
    Williams, David A.
    [J]. MOLECULAR THERAPY, 2007, 15 (10) : 1737 - 1737
  • [7] Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin-binding ability and introduced novel tropism (vol 17, pg 353, 2006)
    Shi, Xiangqun
    Fang, Guangguang
    Shi, Wenfang
    Bartlett, Jeffrey S.
    [J]. HUMAN GENE THERAPY, 2006, 17 (08) : 878 - 878
  • [8] Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
    Wu, P
    Xiao, W
    Conlon, T
    Hughes, J
    Agbandje-McKenna, M
    Ferkol, T
    Flotte, T
    Muzyczka, N
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (18) : 8635 - 8647
  • [9] Recombinant AAV2 and the Endoplasmic Reticulum
    Jiang, Hao-Yuan
    Xiang, Yiwen
    Weigel-Van Aken, Kirsten A. K.
    [J]. MOLECULAR THERAPY, 2009, 17 : S38 - S39
  • [10] Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo
    Li, Chengwen
    Hirsch, Matthew
    Asokan, Aravind
    Zeithaml, Brian
    Ma, Hong
    Kafri, Tal
    Samulski, R. Jude
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (14) : 7540 - 7547